179 related articles for article (PubMed ID: 24074932)
1. Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?
Matney J; Park PC; Bluett J; Chen YP; Liu W; Court LE; Liao Z; Li H; Mohan R
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):576-82. PubMed ID: 24074932
[TBL] [Abstract][Full Text] [Related]
2. Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC.
Giaddui T; Chen W; Yu J; Lin L; Simone CB; Yuan L; Gong YU; Wu QJ; Mohan R; Zhang X; Bluett JB; Gillin M; Moore K; O'Meara E; Presley J; Bradley JD; Liao Z; Galvin J; Xiao Y
Radiat Oncol; 2016 May; 11():66. PubMed ID: 27142674
[TBL] [Abstract][Full Text] [Related]
3. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
[TBL] [Abstract][Full Text] [Related]
5. An in-silico comparison of proton beam and IMRT for postoperative radiotherapy in completely resected stage IIIA non-small cell lung cancer.
Berman AT; Teo BK; Dolney D; Swisher-McClure S; Shahnazi K; Both S; Rengan R
Radiat Oncol; 2013 Jun; 8():144. PubMed ID: 23767810
[TBL] [Abstract][Full Text] [Related]
6. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
Liao Z; Lee JJ; Komaki R; Gomez DR; O'Reilly MS; Fossella FV; Blumenschein GR; Heymach JV; Vaporciyan AA; Swisher SG; Allen PK; Choi NC; DeLaney TF; Hahn SM; Cox JD; Lu CS; Mohan R
J Clin Oncol; 2018 Jun; 36(18):1813-1822. PubMed ID: 29293386
[TBL] [Abstract][Full Text] [Related]
7. Clinical implementation of intensity modulated proton therapy for thoracic malignancies.
Chang JY; Li H; Zhu XR; Liao Z; Zhao L; Liu A; Li Y; Sahoo N; Poenisch F; Gomez DR; Wu R; Gillin M; Zhang X
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):809-18. PubMed ID: 25260491
[TBL] [Abstract][Full Text] [Related]
8. Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors.
Simeonova A; Abo-Madyan Y; El-Haddad M; Welzel G; Polednik M; Boggula R; Wenz F; Lohr F
Radiother Oncol; 2012 Feb; 102(2):268-73. PubMed ID: 22100654
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.
Zhang X; Li Y; Pan X; Xiaoqiang L; Mohan R; Komaki R; Cox JD; Chang JY
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):357-66. PubMed ID: 19660879
[TBL] [Abstract][Full Text] [Related]
10. Anatomic change over the course of treatment for non-small cell lung cancer patients and its impact on intensity-modulated radiation therapy and passive-scattering proton therapy deliveries.
Chen M; Yang J; Liao Z; Chen J; Xu C; He X; Zhang X; Zhu RX; Li H
Radiat Oncol; 2020 Mar; 15(1):55. PubMed ID: 32138753
[TBL] [Abstract][Full Text] [Related]
11. Impact of target volume segmentation accuracy and variability on treatment planning for 4D-CT-based non-small cell lung cancer radiotherapy.
Martin S; Johnson C; Brophy M; Palma DA; Barron JL; Beauchemin SS; Louie AV; Yu E; Yaremko B; Ahmad B; Rodrigues GB; Gaede S
Acta Oncol; 2015 Mar; 54(3):322-32. PubMed ID: 25350526
[TBL] [Abstract][Full Text] [Related]
12. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
Roelofs E; Engelsman M; Rasch C; Persoon L; Qamhiyeh S; de Ruysscher D; Verhaegen F; Pijls-Johannesma M; Lambin P;
J Thorac Oncol; 2012 Jan; 7(1):165-76. PubMed ID: 22071782
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
[TBL] [Abstract][Full Text] [Related]
14. Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer.
Zhang X; Zhao KL; Guerrero TM; McGuire SE; Yaremko B; Komaki R; Cox JD; Hui Z; Li Y; Newhauser WD; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):278-87. PubMed ID: 18722278
[TBL] [Abstract][Full Text] [Related]
15. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.
Register SP; Zhang X; Mohan R; Chang JY
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1015-22. PubMed ID: 20615629
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
[TBL] [Abstract][Full Text] [Related]
17. Perturbation of water-equivalent thickness as a surrogate for respiratory motion in proton therapy.
Matney JE; Park PC; Li H; Court LE; Zhu XR; Dong L; Liu W; Mohan R
J Appl Clin Med Phys; 2016 Mar; 17(2):368-378. PubMed ID: 27074459
[TBL] [Abstract][Full Text] [Related]
18. On the interplay effects with proton scanning beams in stage III lung cancer.
Li Y; Kardar L; Li X; Li H; Cao W; Chang JY; Liao L; Zhu RX; Sahoo N; Gillin M; Liao Z; Komaki R; Cox JD; Lim G; Zhang X
Med Phys; 2014 Feb; 41(2):021721. PubMed ID: 24506612
[TBL] [Abstract][Full Text] [Related]
19. Impact of four-dimensional computed tomography pulmonary ventilation imaging-based functional avoidance for lung cancer radiotherapy.
Yamamoto T; Kabus S; von Berg J; Lorenz C; Keall PJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):279-88. PubMed ID: 20646852
[TBL] [Abstract][Full Text] [Related]
20. Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.
Botas P; Grassberger C; Sharp G; Paganetti H
Phys Med Biol; 2018 Jan; 63(3):035023. PubMed ID: 29219119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
